About Script Semaglutide

What this is

Script Semaglutide is an independent editorial project that publishes summaries of the peer-reviewed research literature on semaglutide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The approach is simple and consistent: lead with what a study measured, attribute it to the source, and mark the gaps instead of filling them. Findings read like logged output — the figures, the trial names, the identifiers — because that is the most honest way to present a large, fast-moving evidence base.

About the name

The word "script" in the name is editorial framing, not a service. This site does not write prescriptions, fill them, or connect anyone to a prescriber. "Script" here marks a position relative to the literature — a place to read the record straight — and nothing about the domain implies clinical care, consultation, or dispensing. There is no doctor behind the name and no pharmacy behind the counter, because there is no counter.

How we handle sources

Every quantitative claim on this site maps to a numbered entry in the references, each a real published study with a DOI or PubMed identifier. We use generic compound names only and name no commercial products. Where the evidence is strong — large randomized trials, replicated across populations — we say so plainly. Where it is early or unsettled, such as the emerging alcohol-craving research, we label it as such rather than dressing it up.

What we do not do

We do not recommend doses for individuals, diagnose, or tell anyone what to take. We do not sell, source, or review vendors of any product, including compounded preparations. We do not invent authors, addresses, or credentials. If a claim is not in the published literature, it is not on this site. For anything about your own health, the right next step is a qualified clinician — not a research log.